Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Prerna K Chawla

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Indian Journal of Clinical Biochemistry : IJCB|April 13, 2016
Plasma Voriconazole Estimation by HPLCPrerna K Chawla, Alpa J Dherai, Tester F Ashavaid
International Journal of Clinical Pharmacy|May 31, 2015
Correlation of CYP2C19 genotype with plasma voriconazole levels: a preliminary retrospective study in IndiansPrerna K Chawla, Shweta R Nanday, Alpa J Dherai, et al.
The Journal of the Association of Physicians of India|October 21, 2016
Importance of Therapeutic Drug Monitoring of RifampicinPrerna K Chawla, Zarir F Udwadia, Rajeev Soman, et al.
Infectious Diseases (London, England)|March 10, 2017
Failure to reach therapeutic levels of rifampicin and isoniazid by recommended dosagesPrerna K Chawla, Rohan V Lokhande, Prasad R Naik, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Indian Journal of Clinical Biochemistry : IJCB|April 13, 2016
Plasma Voriconazole Estimation by HPLCPrerna K Chawla, Alpa J Dherai, Tester F Ashavaid
International Journal of Clinical Pharmacy|May 31, 2015
Correlation of CYP2C19 genotype with plasma voriconazole levels: a preliminary retrospective study in IndiansPrerna K Chawla, Shweta R Nanday, Alpa J Dherai, et al.
The Journal of the Association of Physicians of India|October 21, 2016
Importance of Therapeutic Drug Monitoring of RifampicinPrerna K Chawla, Zarir F Udwadia, Rajeev Soman, et al.
Infectious Diseases (London, England)|March 10, 2017
Failure to reach therapeutic levels of rifampicin and isoniazid by recommended dosagesPrerna K Chawla, Rohan V Lokhande, Prasad R Naik, et al.
Pageof 1